Ruijuan Gao Selected Research

Apoproteins

12/2022	A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer.
9/2010	A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruijuan Gao Research Topics

Disease

7	Neoplasms (Cancer) 12/2022 - 08/2010
1	Esophageal Neoplasms (Esophageal Cancer) 12/2022
1	Diarrhea 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Herpes Zoster 01/2022
1	Pain (Aches) 11/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Cicatrix (Scar) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Hypoxia (Hypoxemia) 03/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2020
1	Necrosis 03/2020
1	Acidosis 12/2018
1	Retinoblastoma (Glioblastoma, Retinal) 12/2018
1	Macular Degeneration (Age-Related Maculopathy) 01/2017
1	Choroidal Neovascularization 01/2017
1	Giant Cell Carcinoma 08/2015
1	Neoplasm Metastasis (Metastasis) 08/2015
1	Hepatocellular Carcinoma (Hepatoma) 08/2015
1	Obesity 02/2012
1	Breast Neoplasms (Breast Cancer) 02/2012
1	Carcinoma (Carcinomatosis) 09/2010
1	Prostatic Neoplasms (Prostate Cancer) 08/2010

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2010
3	Pharmaceutical PreparationsIBA 12/2022 - 12/2018
2	Oxidoreductases (Dehydrogenase)IBA 12/2022 - 12/2018
2	ApoproteinsIBA 12/2022 - 09/2010
2	C 1027IBA 12/2022 - 09/2010
2	AntioxidantsIBA 12/2018 - 01/2017
2	GelatinasesIBA 08/2015 - 09/2010
2	AndrogensIBA 02/2012 - 08/2010
1	Human Serum Albumin FDA LinkGeneric 12/2022
1	ErbB Receptors (EGF Receptor)IBA 12/2022
1	Recombinant Fusion ProteinsIBA 12/2022
1	Immunoconjugates (Immunoconjugate)IBA 12/2022
1	Inosine Monophosphate (IMP)IBA 12/2022
1	Polysaccharides (Glycans)IBA 10/2022
1	Interleukin-4 (Interleukin 4)IBA 10/2022
1	OccludinIBA 01/2022
1	Claudin-1IBA 01/2022
1	zonulinIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Amine Oxidase (Copper-Containing)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Anoctamin-1IBA 11/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Netrin-1IBA 01/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	CollagenIBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 03/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2020
1	CXCR4 Receptors (CXCR4 Receptor)IBA 12/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2018
1	ceric oxide (cerium dioxide)IBA 12/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	glycol-chitosanIBA 01/2017
1	endostar proteinIBA 08/2015
1	Aromatase (CYP19)IBA 02/2012
1	Aromatase InhibitorsIBA 02/2012
1	Estrogens (Estrogen)FDA Link 02/2012
1	Estrogen ReceptorsIBA 02/2012
1	Selenium CompoundsIBA 08/2010
1	Hormones (Hormone)IBA 08/2010
1	SeleniumIBA 08/2010
1	SurvivinIBA 08/2010

Therapy/Procedure

7	Therapeutics 12/2022 - 09/2010
1	Denervation 01/2021
1	Drug Therapy (Chemotherapy) 12/2018
1	Lasers (Laser) 01/2017
1	Chemoprevention 02/2012